Please login to the form below

Not currently logged in
Email:
Password:

EFPIA

This page shows the latest EFPIA news and features for those working in and with pharma, biotech and healthcare.

UK pharma Code of Practice to change with digital times

UK pharma Code of Practice to change with digital times

The code is also expected to see further changes next year to remain in line with changes from the IFPMA and EFPIA codes.

Latest news

More from news
Approximately 36 fully matching, plus 174 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Life science companies, the ABPI and EFPIA have been clear that the UK and the EU need to provide businesses with ‘certainty’so that they are able to create contingency plans

  • Brexit Means Brexit Brexit Means Brexit

    These common-sense ambitions are broadly aligned with those of EFPIA and pharmaceutical companies across Europe.

  • A quest for innovative solutions A quest for innovative solutions

    Increase returns. UCB is one of the partners in a consortium that includes other EFPIA companies, universities, research organisations, public bodies, non-profit groups and other third parties.

  • Healthcare systems

    Healthcare terms - Healthcare systems.

  • The sound of silence puts the squeeze on generics and biosimilars The sound of silence puts the squeeze on generics and biosimilars

    Fair proposal. He believes lobbying by the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents 33 national associations and 42 leading pharmaceutical companies, is blocking a revenue stream and ... EFPIA issued a

More from intelligence
Approximately 6 fully matching, plus 28 partially matching documents found.

Latest appointments

  • EFPIA appoints new director general EFPIA appoints new director general

    EFPIA appoints new director general. Nathalie Moll takes up the role from April. ... Joe Jiminez, president of EFPIA, said: “ Nathalie has an excellent track record of leadership and engagement across the life science sector. “

  • IFPMA appoints director general IFPMA appoints director general

    IFPMA appoints director general. Thomas Cueni brings expertise from Interpharma and EFPIA. ... Cueni also brings industry expertise from the European Federation of Pharmaceutical Industries and Associations (EFPIA), where he served in a policy-shaping

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    He also brings branding and sales leadership experience from Novar tis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    Eric Cornut appointed EFPIA interim director general. Steps into the role as Richard Bergström leaves the association. ... work. “ I am very pleased that Eric accepted to lead EFPIA ad interim.”.

  • EFPIA director general Richard Bergström resigns EFPIA director general Richard Bergström resigns

    EFPIA director general Richard Bergström resigns. Will remain in the role until a successor has been selected. ... Richard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his

More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Leveraging HCP Transparency Insights to Drive Future Customer Investments

    Leveraging HCP Transparency Insights to Drive Future Customer Investments. EFPIA’ s disclosure requirements present an opportunity to assess strategy and effectiveness.

  • How Transparent Is Transparency?

    So, what have we learnt? Is the  EFPIA mission – to provide a greater understanding of the merits and ethics of the interactions between pharmaceutical companies and healthcare professionals (HCPs) – bearing any ... The EFPIA vision of enhanced

  • Brexit and Pharma: A match made in hell.

    Brexit and Pharma: A match made in hell. My husband and I woke up in the early hours of 24 June 2016 to the astonishing news that the UK had voted to leave the EU. It’ s fair to say both of us shuddered and, while our perspectives were different,

  • The changing face of medical communications over the past 15 years

    Similarly, the launch of Disclosure UK’ s searchable database, which went live in June 2016, is a helpful development for the UK (and Europe-wide through EFPIA), although details don’ t

  • EY Life Sciences

    EFPIA’ s disclosure requirements present an opportunity to assess strategy and effectiveness.

More from PMHub
Approximately 2 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics